Related Experiment Video
Updated: Aug 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Organising pneumonia in connection with Amiodarone treatment. Case reports and review]
Olafur A Sveinsson1, Helgi J Isaksson, Gunnar Guethmundsson
1Lung Department, Iceland University Hospital, Fossvogi, 108 Reykjavík, Iceland.
Objective:
The objective of the study was to describe case reports of organising pneumonia in Iceland induced by the drug amiodarone.
Material And Methods:
Retrospective study where information was obtained from clinical charts from 1984-2003. Medical records, imaging studies and histopathology were re-evaluated.
Results:
Described are three case reports of organising pneumonia associated with amiodarone use in two males and one female. Diagnostic methods and treatment are described and current literature is discussed.
Conclusions:
It is important for physicians to be aware of lung changes that amiodarone can cause and the importance of monitoring these patients.
Insights
Amiodarone can cause organizing pneumonia, a lung condition. Physicians must monitor patients for these amiodarone-induced lung changes.
Area of Science:
- Pulmonology
- Cardiology
- Pharmacology
Background:
- Amiodarone is a widely used antiarrhythmic drug.
- Drug-induced lung injury is a known adverse effect of amiodarone.
- Organizing pneumonia is a pattern of lung injury that can be caused by medications.
Observation:
- This study describes three cases of organizing pneumonia in Iceland linked to amiodarone use.
- The cases involved two males and one female patient.
- Data were collected retrospectively from 1984-2003, with re-evaluation of medical records, imaging, and histopathology.
Findings:
- The three patients presented with organizing pneumonia attributed to amiodarone.
- Diagnostic approaches and treatment strategies for these cases are detailed.
- The findings highlight a specific presentation of amiodarone-induced lung disease.
Implications:
- Physicians should be vigilant for organizing pneumonia in patients taking amiodarone.
- Awareness of amiodarone's potential pulmonary toxicity is crucial for patient management.
- Regular monitoring for lung changes in patients on amiodarone is recommended.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.